JYHZ2000180 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | License Renew | 2020-06-28 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2020-12-07 | view |
JYHZ2000179 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | License Renew | 2020-06-28 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2020-12-07 | view |
JYHZ2000178 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | License Renew | 2020-07-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2020-12-07 | view |
JYHZ2000177 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | License Renew | 2020-07-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2020-12-07 | view |
JYHS2300045 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-03-29 | | Dr Reddy's Laboratories Ltd | | | view |
JYHS2300044 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-03-29 | | Dr Reddy's Laboratories Ltd | | | view |
JYHS2100050 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | Dr.Reddy\'s Laboratories Limited | Dr Reddy's Laboratories Ltd | In Review | 2021-03-25 | view |
JYHS2100049 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | Dr.Reddy\'s Laboratories Limited | Dr Reddy's Laboratories Ltd | In Review | 2021-03-25 | view |
JYHF1800127 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2018-10-25 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2018-11-16 | view |
JYHF1800126 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2018-10-25 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Certificate Issued | 2018-11-16 | view |
JYHB2500141 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2025-03-11 | | CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl | | | view |
JYHB2500140 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2025-03-11 | | CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl | | | view |
JYHB2500139 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2025-03-11 | | CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl | | | view |
JYHB2500138 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2025-03-11 | | CHEPLAPHARM Schweiz GmbH;Delpharm Milano Srl | | | view |
JYHB2101365 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-08-24 | | Delpharm Milano Srl;Roche Registration GmbH | | | view |
JYHB2101364 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-08-24 | | Delpharm Milano Srl;Roche Registration GmbH | | | view |
JYHB2101363 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-08-24 | | Delpharm Milano Srl;Roche Registration GmbH | | | view |
JYHB2101362 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-08-24 | | Delpharm Milano Srl;Roche Registration GmbH | | | view |
JYHB2001295 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-08-06 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Filed | 2020-08-19 | view |
JYHB2001294 | 盐酸厄洛替尼片 | erlotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-08-06 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Delpharm Milano Srl;Roche Registration GmbH | Filed | 2020-08-19 | view |